Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Discharge During the Weekend After Cardiac Surgery Is Not Associated with Readmissions

According to this new work (soon to be published in Ann Thorac Surg), discharging a patient during the weekend or a holiday after cardiac surgery is not associated with higher rates of readmission compared with patients discharged during weekdays.

El alta en el mismo día luego de una angioplastia coronaria es cada vez más popular pero todavía no es reglaA total of 4877 patients were discharged after cardiac surgery in high-volume sites in the United States. Among them, about 1 every 5 patients was discharged on a Saturday, Sunday, or holiday, and 11.4% had to be readmitted within 30 days.

 

Conversely, 10.9% of the patients who went home on a weekday had to go back to the hospital within the same period of time. The difference between cohorts is not significant.


Read also: Next-Day Discharge after TAVR: Is It Viable?


Discharge is a task that begins immediately after surgery and that must include a patient’s family so that, once s/he gets home, s/he has the necessary resources to meet expectations.

 

Several studies in diverse clinical contexts have shown an increase in the number of events upon admission during the weekend; however, according to this work, going home on a weekend does not entail the same risks.

 

Some comorbidities (older age, chronic obstructive pulmonary disease, dialysis, pleural effusion after surgery, or neurological complications) had previously been associated with more readmissions but were not predictors in this cohort.


Read also: Transradial Access and Early Discharge in Percutaneous Interventions.


Smoking and beta-blocker use were actually associated with more readmissions. However, in the case of beta-blockers, the problem may not lie in their use, but in the fact that they suggest a higher burden of ischemic disease.

 

Original title: Day of Discharge Does Not Impact Hospital Readmission After Major Cardiac Surgery.

Reference: Sanaiha Y et al. Ann Thorac Surg 2018; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...